-Yoshiaki Isobe Researcher Activity Profile

Research Author Detailed Information 

Yoshiaki Isobe Publication Rate By Year

Yoshiaki Isobe has published 1 paper(s) in 1990, 1 paper(s) in 1999, 2 paper(s) in 2004, 9 paper(s) in 2007, 2 paper(s) in 2008, for a total of 15 research publications in total.

Yoshiaki Y Isobe Author Information

LAST NAME: isobe

FIRST NAME: Yoshiaki

INITIALS: y

AFFILIATION:

Papers

Yoshiaki Isobe's Publication Record

1. Signal transmission from the suprachiasmatic nucleus to the pineal gland via the paraventricular nucleus: analysed from arg-vasopressin peptide, rPer2 mRNA and AVP mRNA changes and pineal AA-NAT mRNA after the melatonin injection during light and dark periods. Year Published: 2004
Department of Neuro-physiology and Brain Sciences, Nagoya City University, Graduate School of Medical Sciences, Mizuho, Nagoya 467-8601, Japan. yisobe@med.nagoya-cu.ac.jp
2. Cycloalkanediamine derivatives as novel blood coagulation factor Xa inhibitors. Year Published: 2007
Medicinal Chemistry Research Laboratory, Daiichi Pharmaceutical Co., Ltd, 1-16-13, Kita-Kasai, Edogawa-ku, Tokyo 134-8630, Japan. nagatso1@daiichipharm.co.jp
3. Increase in neurogenesis and neuroblast migration after a small intracerebral hemorrhage in rats. Year Published: 2007
Department of Neurophysiology and Brain Science, Nagoya City University Graduate School of Medical Sciences, Nagoya 467-8601, Japan.
4. Clinical significance of perioperative immunonutrition for patients with esophageal cancer. Year Published: 2007
Department of Surgery, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan. hiroyatakeuchi@aol.com
5. Pretreatment plasma fibrinogen level correlates with tumor progression and metastasis in patients with squamous cell carcinoma of the esophagus. Year Published: 2007
Department of Surgery, National Tokyo Medical Center, Meguro-ku, Tokyo, Japan.
6. Up-regulation of telomerase in primary cultured rat hepatocytes. Year Published: 1999
Laboratory of Cancer Cell Biology, Research Institute for Disease Mechanism and Control, Showa-ku, Nagoya, 466-8550, Japan.
7. Carboxyflavins, novel inhibitors of Taq DNA polymerase. Year Published: 2007
Department of Applied Biological Science, Faculty of Science and Technology, Science University of Tokyo, 2641 Yamazaki, Noda, Chiba 278-8510, Japan.
8. Increase in neurogenesis and neuroblast migration after a small intracerebral hemorrhage in rats. Year Published: 2007
Department of Neurophysiology and Brain Science, Nagoya City University Graduate School of Medical Sciences, Nagoya 467-8601, Japan.
9. Clinical significance of perioperative immunonutrition for patients with esophageal cancer. Year Published: 2007
Department of Surgery, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan. hiroyatakeuchi@aol.com
10. Emission control for precursors causing acid rain (V): Improvement of acid soil with the bio-briquette combustion ash. Year Published: 2004
Sino-Japanese Friendship Center for Environmental Protection, Beijing 100029, China. xhdong@cneac.com
11. Pretreatment plasma fibrinogen level correlates with tumor progression and metastasis in patients with squamous cell carcinoma of the esophagus. Year Published: 2007
Department of Surgery, National Tokyo Medical Center, Meguro-ku, Tokyo, Japan. hiroyatakeuchi@aol.com
12. Inflammatory pseudotumor of the liver. Year Published: 1990
13. Pretreatment plasma fibrinogen level correlates with tumor progression and metastasis in patients with squamous cell carcinoma of the esophagus. Year Published: 2007
Department of Surgery, National Tokyo Medical Center, Meguro-ku, Tokyo, Japan. hiroyatakeuchi@aol.com
14. Potential prognostic benefits of radiotherapy as an initial treatment for patients with unresectable advanced hepatocellular carcinoma with invasion to intrahepatic large vessels. Year Published: 2008
Gastroenterology Division of Internal Medicine, Kitasato University East Hospital, Sagamihara, Japan.
15. Potential prognostic benefits of radiotherapy as an initial treatment for patients with unresectable advanced hepatocellular carcinoma with invasion to intrahepatic large vessels. Year Published: 2008
Gastroenterology Division of Internal Medicine, Kitasato University East Hospital, Sagamihara, Japan. tnakazaw@kitasato-u.ac.jp